During this session, participants will discuss updates to the CDC’s 2024 adult vaccine schedule. As a part of this presentation, new vaccines for use in adult patients will be discussed (RSV, pentavalent meningococcal). Utilizing patient cases, participants will apply the updated ACIP guidance to determine appropriate vaccine recommendations.